Report cover image

India Pharmaceuticals Market

Publisher BlueWeave Consulting
Published Jul 24, 2025
Length 135 Pages
SKU # BLWC20706782

Description

India Pharmaceuticals Market, By Therapeutic Category (Anti-Infectives, Cardiovascular, Gastrointestinal, Anti-Diabetic, Respiratory, Dermatology, Musculoskeletal System, Central Nervous System); By Drug Type (Generic Prescription Drugs, Over the Counter (OTC) Medications, Active Pharmaceutical Ingredients (APIs), Biosimilars, Vaccines); By Route of Administration (Inhalation, Parenteral, Topical, Transdermal); By Region (North India, West India, South India, East India), Trend Analysis, Competitive Landscape & Forecast, 2019–2031India Pharmaceuticals Market More Than Doubles Its Size to Cross USD 123 Billion by 2031

India Pharmaceuticals Market is booming primarily due to a surging demand for generics, growing exports to countries across the regions, innovations, government’s incentives, and rising prevalence of chronic diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated India Pharmaceuticals Market size by value at USD 60.83 billion in 2024. During the forecast period between 2025 and 2031, BlueWeave expects India Pharmaceuticals Market size to boom at a robust CAGR of 10.6%, reaching a value of USD 123.14 billion by 2031. The expansion of India Pharmaceuticals Market is driven by increasing prevalence of chronic diseases, rapidly aging population, and expanding healthcare access. The Indian government’s supportive incentives like PLI schemes and Ayushman Bharat boost production and affordability. Increased health insurance coverage, digital adoption, and demand for generics fuel growth. Export strength, skilled workforce, and low manufacturing costs enhance global competitiveness. Innovations in biosimilars, telemedicine, and R&D partnerships further accelerate the expansion of India Pharmaceuticals Market. Urbanization and lifestyle changes also raise demand for advanced therapies and preventive care.

Opportunity – Growing Demand for Biosimilars and Biologics

India biosimilars and biologics segment is expanding rapidly due to rising chronic disease prevalence, patent expiries of biologics, and cost-effective manufacturing. With over 100 approved biosimilars, India is a global leader in affordable biologic alternatives. Government incentives, streamlined regulations, and strategic collaborations with global firms fuel innovation and exports. Domestic players like Biocon and Dr. Reddy’s are launching biosimilars in international markets, reinforcing India’s position as a biosimilar hub. Hence, a surging demand for biologics and biosimilars is expected to further boost the growth of India Pharmaceuticals Market in the coming years.

Parenteral Products Segment India Pharmaceuticals Market

The parenteral products segment holds the largest and fastest-growing segment in India Pharmaceuticals Market. Parenteral products account for a significant portion of the market. The segment’s market dominance stems from a rising demand for sterile injectables, biologics, and hospital-based therapies. Parenteral drugs offer rapid efficacy and are preferred for chronic and acute conditions, making them a cornerstone of India Pharmaceuticals MArket.

Impact of Escalating Geopolitical Tensions on India Pharmaceuticals Market

Escalating geopolitical tensions, especially U.S. tariff threats, pose significant risks to the growth of India Pharmaceuticals Market. Proposed 200% duties on drug exports could disrupt supply chains, dampen demand, and inflate costs. India’s reliance on U.S. markets—over 36% of exports—makes it vulnerable. Trade uncertainty may delay investments and force firms to diversify markets. However, shifts like the BIOSECURE Act offer opportunities to replace Chinese suppliers. Overall, tensions create volatility but also strategic openings for the players in India Pharmaceuticals Market.

Competitive Landscape

India Pharmaceuticals Market is highly fragmented, with numerous players serving the market. Major companies dominating the market are Sun Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd, Cipla Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Torrent Pharmaceuticals Ltd, Zydus Lifesciences Ltd, Glenmark Pharmaceuticals Ltd, Alkem Laboratories Ltd, Intas Pharmaceuticals Ltd, and Biocon Ltd. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge over their competitors in India Pharmaceuticals Market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and India Pharmaceuticals Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in India Pharmaceuticals Market, along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

135 Pages
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. India Pharmaceuticals Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Expansion of Health Insurance Coverage
3.2.1.2. Rising Demand for Chronic Disease Therapies
3.2.1.3. Government Support via Production Linked Incentive (PLI) Schemes
3.2.2. Restraints
3.2.2.1. High Dependence on Imported Active Pharmaceutical Ingredients (APIs)
3.2.2.2. Regulatory Delays in Drug Approvals
3.2.2.3. Price Controls under National List of Essential Medicines (NLEM)
3.2.3. Opportunities
3.2.3.1. Growth in Biosimilars and Biologics Segment
3.2.3.2. Digital Health and E-Pharmacy Expansion
3.2.4. Challenges
3.2.4.1. Infrastructure Gaps in Cold Chain and Advanced Manufacturing
3.2.4.2. Limited Investment in Research and Development (R&D)
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. India Pharmaceuticals Market: Marketing Strategies
5. India Pharmaceuticals Market: Pricing Analysis
6. India Pharmaceuticals Market Overview
6.1. Market Size & Forecast, 2019–2031
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Therapeutic Category
6.2.1.1. Anti-Infectives
6.2.1.2. Cardiovascular
6.2.1.3. Gastrointestinal
6.2.1.4. Anti-Diabetic
6.2.1.5. Respiratory
6.2.1.6. Dermatology
6.2.1.7. Musculoskeletal System
6.2.1.8. Central Nervous System
6.2.2. By Drug Type
6.2.2.1. Generic Prescription Drugs
6.2.2.2. Over the Counter (OTC) Medications
6.2.2.3. Active Pharmaceutical Ingredients (APIs)
6.2.2.4. Biosimilars
6.2.2.5. Vaccines
6.2.3. By Route of Administration
6.2.3.1. Inhalation
6.2.3.2. Parenteral
6.2.3.3. Topical
6.2.3.4. Transdermal
6.2.4. By Region
6.2.4.1. North India
6.2.4.2. West India
6.2.4.3. South India
6.2.4.4. East India
7. Competitive Landscape
7.1. List of Key Players and Their Offerings
7.2. Nigeria Insurance Company Market Share Analysis, 2024
7.3. Competitive Benchmarking, By Operating Parameters
7.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
8. Impact of Escalating Geopolitical Tensions on India Pharmaceuticals Market
9. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
9.1. Sun Pharmaceutical Industries Ltd
9.2. Dr. Reddy’s Laboratories Ltd
9.3. Cipla Ltd
9.4. Lupin Ltd
9.5. Aurobindo Pharma Ltd
9.6. Torrent Pharmaceuticals Ltd
9.7. Zydus Lifesciences Ltd
9.8. Glenmark Pharmaceuticals Ltd
9.9. Alkem Laboratories Ltd
9.10. Intas Pharmaceuticals Ltd
9.11. Biocon Ltd
10. Key Strategic Recommendations
11. Research Methodology
11.1. Qualitative Research
11.1.1.Primary & Secondary Research
11.2. Quantitative Research
11.3. Market Breakdown & Data Triangulation
11.3.1.Secondary Research
11.3.2.Primary Research
11.4. Breakdown of Primary Research Respondents, By Region
11.5. Assumptions & Limitations
*Financial information of case of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.
List of Figures
Figure 1 Nigeria Insurance Segmentation
Figure 2 India Pharmaceuticals Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2024
Figure 4 India Pharmaceuticals Market Size, By Value (USD Billion), 2019–2031
Figure 5 India Pharmaceuticals Market Share, By Product Type, By Value, 2019–2031
Figure 6 India Pharmaceuticals Market Share, By Therapeutic, By Value, 2019–2031
Figure 7 India Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2031
List of Tables
Table 1 India Pharmaceuticals Market Size, By Value (USD Billion), 2019–2031
Table 2 India Pharmaceuticals Market Size, By Therapeutic, By Value, 2019–2031
Table 3 India Pharmaceuticals Market Size, By Drug Type, By Value, 2019–2031
Table 4 India Pharmaceuticals Market Size, By Route of Administration, By Value, 2019–2031
Table 5 India Pharmaceuticals Market Size, By Region, By Value, 2019–2031
Table 6 Sun Pharmaceutical Industries Ltd Company Overview
Table 7 Sun Pharmaceutical Industries Ltd Financial Overview
Table 8 Dr. Reddy’s Laboratories Ltd Company Overview
Table 9 Dr. Reddy’s Laboratories Ltd Financial Overview
Table 10 Cipla Ltd Company Overview
Table 11 Cipla Ltd Financial Overview
Table 12 Lupin Ltd Company Overview
Table 13 Lupin Ltd Financial Overview
Table 14 Aurobindo Pharma Ltd Company Overview
Table 15 Aurobindo Pharma Ltd Financial Overview
Table 16 Torrent Pharmaceuticals Ltd Company Overview
Table 17 Torrent Pharmaceuticals Ltd Financial Overview
Table 18 Zydus Lifesciences Ltd Company Overview
Table 19 Zydus Lifesciences Ltd Financial Overview
Table 20 Glenmark Pharmaceuticals Ltd Company Overview
Table 21 Glenmark Pharmaceuticals Ltd Financial Overview
Table 22 Alkem Laboratories Ltd Company Overview
Table 23 Alkem Laboratories Ltd Financial Overview
Table 24 Intas Pharmaceuticals Ltd Company Overview
Table 25 Intas Pharmaceuticals Ltd Financial Overview
Table 26 Biocon Ltd Company Overview
Table 27 Biocon Ltd Financial Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us